Your account is not claimed yet. You can sign up with ORCID to claim your account.

Shuyang Chen

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Insulin Resistance

Top Venues

Cancer research

NPJ precision oncology

Nature communications

Boston University Medical Campus

Drexel University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boston University Medical Campus

United States

Postdoctoral Associate :: Pharmacology and Experimental Therapeutics

Education History

Drexel University

United States

PHD :: Biology

Publications

Yu Sun, Xin Li, Chengqian Yin, Judy Zhang, Ershang Liang, Xianfang Wu, Ying Ni, Joshua Arbesman, Colin R Goding, Shuyang Chen
AMPK phosphorylates ZDHHC13 to increase MC1R activity and suppress melanomagenesis. Cancer research (2023)
Vipin Shankar Chelakkot, Kiara Thomas, Todd Romigh, Andrew Fong, Lin Li, Shira Ronen, Shuyang Chen, Pauline Funchain, Ying Ni, Joshua Arbesman
MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. NPJ precision oncology 7 (1) (2023)
Shuyang Chen, Changpeng Han, Xiao Miao, Xin Li, Chengqian Yin, Junrong Zou, Min Liu, Shanshan Li, Lukasz Stawski, Bo Zhu, Qiong Shi, Zhi-Xiang Xu, Chunying Li, Colin R Goding, Jun Zhou, Rutao Cui
Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads. Nature communications 10 (1) (2019)